Medical Imaging on the Cloud: Testing for Trust

Almost two-thirds of health systems are already using (or plan to use) the cloud for storing and viewing medical images. CT scans, MRIs and X-rays are now routinely captured, stored, and shared online. The shift makes sense: the cloud makes it easier to scale, collaborate across locations, and apply AI models to large datasets. But as hospitals move more of their imaging to the cloud, they’re also discovering that it brings a new set of challenges along with those advantages.

Oct., 2025 — Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis, has introduced its PlaqueIQ image analysis software for the quantification and classification of plaque morphology in the carotid arteries. The first and only CT-based plaque analysis software indicated for the carotid vasculature, PlaqueIQ may help physicians diagnose carotid plaques at risk for rupture and develop patient-specific treatment pathways to prevent and monitor against ischemic stroke.

Oct. 28, 2025 — QT Imaging Holdings, Inc., a medical device company focused on radiation-free imaging technology, has announced a strategic collaboration with Intelerad Medical Systems. The agreement establishes the deployment of InteleShare Research picture archiving and communication systems (PACS) and Cloud PACS across QT Imaging’s clinical research and commercial networks.

Oct. 27, 2025 — A new study from the Harvey L. Neiman Health Policy Institute found that radiologists who experienced closure of their practice were 10% more likely to subsequently practice as a subspecialist (i.e., majority practice in one area — abdomen, breast, cardiothoracic, musculoskeletal, neuroradiology, nuclear medicine or vascular and interventional radiology). The study, published in the Journal of the American College of Radiology (JACR), was based on nearly 240,000 radiologist-years between 2014 and 2021.

Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for electrophysiology (EP) and interventional cardiology (IC) procedures, recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company's YorLabs Intracardiac Imaging System — a zero-capex ultrasound platform designed to simplify workflow, reduce cost, and enhance procedural efficiency inside the cath lab.

Revealing the Hidden Threat: How AI is Changing the Story of Interval Breast Cancers

Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists: interval cancers — breast cancers that appear between regular screening rounds after an initial “negative” mammogram. Often fast-growing and aggressive, these cancers can account for a significant proportion of clinically relevant misses, even in the era of digital breast tomosynthesis (DBT).

Oct. 23, 2025 — Working together, Grundium, a specialist in digital imaging for pathology, and Washington University, St. Louis (WashU), have shown that Grundium’s technology matches the diagnostic accuracy of traditional methods while decreasing turnaround times and improving patient care. Using Grundium's compact scanners, the university’s pathology team transformed how rapid on-site evaluations (ROSE) and frozen sections are performed across six different locations.

Oct. 22, 2025 —  Fujifilm Healthcare Americas Corp. has launched its advanced endoscopy platform, the ELUXEO 8000 Endoscopic Imaging System — a smartly designed single-unit processor and light source (EP-8000) featuring several features that enhance endoscopic image quality, therapeutic capabilities, and workflow efficiencies. The next-generation platform will be demonstrated at the American College of Gastroenterology (ACG) 2025 Oct.r 26 -28, in Phoenix, Arizona.

Oct. 22, 2025 — Imaging technology company Adaptix has begun live imaging trials as part of a research program at the University of Exeter.

Oct. 22, 2025 — Vistim Labs has announced that its flagship product, Ceregram, is officially ready for launch in neurology offices in the United States, marking a major milestone in the company’s mission to transform how clinicians monitor the effectiveness of treatment for dementia, Alzheimer’s, Parkinson's and other neurological conditions. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now